Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of coronary artery bypass surgery with or without autologous skeletal myoblast injection in patients with prior myocardial infarction
2006-000955-17Phase 2Completed
- Sponsor
- NASERTIC
- Start
- Apr 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous skeletal myoblasts in myocardial infarction (MI) (2 arms), sponsored by NASERTIC. Primary endpoint: Improvement in ventricular function by echocardiography. Started Apr 2010; status: completed.
02
Drugs
autologous skeletal myoblasts
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2006-000955-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000955-17.